Skip to main content
. 2023 May 19;13:1152931. doi: 10.3389/fonc.2023.1152931

Table 2.

Univariate and multivariate analysis of colon cancer overall survival based on the training cohort.

Univariate analysis Multivariate analysis
Log rank χ2 test P-value HR (95%CI) P-value
Age 85.866 < 0.001 < 0.001
 < 65 reference
 ≥ 65 1.448 (1.315-1.595)
Gender 0.012 0.912 NI
 Female
 Male
Race 3.420 0.181 NI
 White
 Black
 Other a
Grade 140.085 < 0.001 < 0.001
 I reference
 II 0.948 (0.724-1.241)
 III 1.365 (1.037-1.796)
 IV 1.506 (1.110-2.044)
T stage 285.727 < 0.001 < 0.001
 T1 reference
 T2 1.586 (0.612-4.109)
 T3 1.958 (0.806-4.755)
 T4 2.972 (1.222-7.227)
N stage 258.274 < 0.001 < 0.001
 N0 reference
 N1 1.677 (1.444-4.109)
 N2 1.733 (1.478-2.032)
M stage 710.426 < 0.001 < 0.001
 M0 reference
 M1 3.058 (2.763-3.384)
Surgery 1.028 0.311 NI
 No
 Yes
Radiotherapy 0.001 0.976 NI
 No/unknown
 Yes
Chemotherapy 144.422 < 0.001 < 0.001
 No/unknown reference
 Yes 0.338 (0.306-0.374)
Tumor size 97.624 <0.001 < 0.001
 <3cm reference
 3-5cm 1.121 (0.956-1.315)
 >5cm 1.329 (1.133-1.559)
CEA 207.361 < 0.001 < 0.001
 Negative/normal reference
 Positive/elevated 1.401 (1.268-1.548)
Insurance 9.125 0.010 0.029
 Any Medicaid reference
 Insured 0.880 (0.778-0.995)
 Uninsured 1.090 (0.869-1.366)
Marital status 45.317 < 0.001 < 0.001
 Married reference
 Unmarried 1.242 (1.136-1.359)

T, Tumor; N, Node; M, Metastasis; CEA, carcinoembryonic antigen; NI, not included in the multivariate survival analysis.

a

other includes American Indian/AK Native, Asian/Pacific Islander and unknowns.